Literature DB >> 7679337

The clinical chemistry laboratory and acute pancreatitis.

E C Wong1, A W Butch, J L Rosenblum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679337

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis.

Authors:  Xiang-Yu Kong; Yi-Qi Du; Lei Li; Jian-Qiang Liu; Guo-Kun Wang; Jia-Qi Zhu; Xiao-Hua Man; Yan-Fang Gong; Li-Ning Xiao; Yong-Zhi Zheng; Shang-Xin Deng; Jun-Jun Gu; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

2.  Chylous ascites secondary to hyperlipidemic pancreatitis with normal serum amylase and lipase.

Authors:  Fahmi-Yousef Khan; Issa Matar
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

3.  Postburn pancreatitis.

Authors:  C M Ryan; R L Sheridan; D A Schoenfeld; A L Warshaw; R G Tompkins
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

4.  Evaluation of amylase and lipase levels in blunt trauma abdomen patients.

Authors:  Subodh Kumar; Sushma Sagar; Arulselvi Subramanian; Venencia Albert; Ravindra Mohan Pandey; Nitika Kapoor
Journal:  J Emerg Trauma Shock       Date:  2012-04

5.  Association between red blood cell distribution width and acute pancreatitis.

Authors:  Keziban Uçar Karabulut; Hüseyin Narcı; Yıldız Uçar; Mehmet Uyar
Journal:  Med Sci Monit       Date:  2014-11-27

Review 6.  Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.

Authors:  Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

7.  Predictors of acute pancreatitis with low elevation of serum amylase.

Authors:  Wandong Hong; Wujun Geng; Bicheng Chen; Zarrin Basharat; Qingsong Wu; Vincent Zimmer; Mengtao Zhou
Journal:  Ther Clin Risk Manag       Date:  2017-12-14       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.